Newbridge Financial Services Group’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-41
Closed -$2.04K 1231
2023
Q3
$2.04K Hold
41
﹤0.01% 1072
2023
Q2
$2.44K Hold
41
﹤0.01% 1110
2023
Q1
$2.32K Hold
41
﹤0.01% 1177
2022
Q4
$3.04K Hold
41
﹤0.01% 1152
2022
Q3
$2K Hold
41
﹤0.01% 1194
2022
Q2
$2K Hold
41
﹤0.01% 1179
2022
Q1
$3K Hold
41
﹤0.01% 1200
2021
Q4
$3K Hold
41
﹤0.01% 1158
2021
Q3
$3K Hold
41
﹤0.01% 1113
2021
Q2
$3K Hold
41
﹤0.01% 1213
2021
Q1
$3K Buy
+41
New +$2.6K ﹤0.01% 1115

Other funds holding GMED

Newbridge Financial Services Group's GMED Position: Q4 2023 in Review

Newbridge Financial Services Group sold out of Globus Medical (GMED) in Q4 2023, closing a stake of 41 shares — an estimated $2.04K sold.

Newbridge Financial Services Group first reported a position in GMED in Q1 2021 and held it in 11 quarters. The position peaked at $3.04K in Q4 2022. 408 funds tracked by Wall St. Rank hold GMED as of Q4 2023.

  • Newbridge Financial Services Group reported no remaining Globus Medical position as of Q4 2023 after selling out during the quarter.
  • Newbridge Financial Services Group sold 41 Globus Medical shares in Q4 2023, an estimated $2.04K.
  • Newbridge Financial Services Group first reported a position in Globus Medical in Q1 2021 and held it in 11 quarters.
  • Newbridge Financial Services Group's Globus Medical position peaked at $3.04K in Q4 2022.
  • 408 funds tracked by Wall St. Rank held Globus Medical as of Q4 2023.

Based on Newbridge Financial Services Group's 13F filing for Q4 2023, filed 28 Mar 2024.